William E. Fantegrossi

Emerging Designer Drugs

David E. Nichols, William E. Fantegrossi, W. Fantegrossi, 2014 .

Phase I Hydroxylated Metabolites of the K2 Synthetic Cannabinoid JWH-018 Retain In Vitro and In Vivo Cannabinoid 1 Receptor Affinity and Activity

William E. Fantegrossi, Jeffery H. Moran, Lisa K. Brents, 2011, PloS one.

Quantitative measurement of JWH-018 and JWH-073 metabolites excreted in human urine.

James B. Kramer, William E. Fantegrossi, Jeffery H. Moran, 2011, Analytical chemistry.